Abstract
The COVID-19 pandemic has drastically altered urban travel patterns, particularly in public transportation systems like subways. This study examines the effects of the pandemic on subway ridership in Beijing by analyzing the influence of 19 factors, including demographics, land use, network metrics, and weather conditions, before and during the pandemic. Data was collected from June 2019 and June 2020, covering 335 subway stations and over 258 million trips. Using a three-stage analytical framework—comprising Light Gradient Boosting Machine (LightGBM) for fitting, Meta-Learners for causal analysis, and SHapley Additive exPlanations (SHAP) for interpretation—we observed a substantial decline in ridership, with approximately 10,000 fewer passengers per station daily, especially in densely populated areas. Our findings reveal significant shifts in influential factors such as centrality, housing prices, and restaurant density. The spatiotemporal analysis highlights the dynamic nature of these changes. This study underscores the need for adaptive urban planning and provides insights for public health strategies to enhance urban resilience in future pandemics.
Significance The COVID-19 pandemic has highlighted the vulnerabilities of urban transportation systems, especially subways, to sudden disruptions. This study explores how various factors influencing subway ridership in Beijing changed during the pandemic, revealing significant shifts in travel patterns. By understanding these changes, we can better prepare for future public health emergencies and improve urban resilience. Our research provides critical insights for urban planners, public health officials, and policymakers, enabling them to make informed decisions that enhance the adaptability and sustainability of urban environments in the face of global challenges.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by the National Natural Science Foundation of China (No. 72091514), the Sanming Project of Medicine in Shenzhen Municipality (No. 20212001132), the Bill & Melinda Gates Foundation (No. INV-018302), and the Natural Science Foundation of Beijing Municipality-Fengtai Rail Transit Frontier Research Joint Fund (No. L211002).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data is included in the article and/or supporting information.
